Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic study of pemetrexed with cisplatin and vitamin supplementation in unresectable pleural mesothelioma
2006-004573-95Phase 2Active
- Sponsor
- Centre Oscar Lambret
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed and cisplatin in pleural mesothelioma, sponsored by Centre Oscar Lambret. Primary endpoint: Pharmacokinetic criteria. Started Mar 2007; status: active.
02
Drugs
pemetrexedcisplatin
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2006-004573-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004573-95.